Tryptophan and inhibitors of tryptophan 2,3-dioxygenase as antidepressants: Reply

Badawy AA-B (2013) Perspective: Tryptophan: The key to boosting brain serotonin synthesis in depressive illness. J Psychopharmacol 27: 878–893.

Badawy AA-B Evans M (1974) Guinea pig liver tryptophan pyrrolase – absence of detectable apoenzyme activity and of hormonal induction by cortisol and possible regulation by tryptophan. Biochem J 138: 445–451

Badawy AA-B Evans M (1975) The regulation of rat liver tryptophan pyrrolase by its cofactor haem – experiments with haematin and 5-aminolaevulinate and comparison with the substrate and hormonal mechanisms. Biochem J 150: 511–520.

Badawy AA-B Evans M (1976a) Animal liver tryptophan pyrrolases – absence of apoenzyme and of hormonal induction mechanism from species sensitive to tryptophan toxicity. Biochem J 158: 79–88.

Badawy AA-B Evans M (1976b) The role of free serum tryptophan in the biphasic effect of acute ethanol administration on the concentrations of rat brain tryptophan, 5-hydroxytryptamine and 5-hydroxyindol-3-ylacetic acid. Biochem J 160: 315–324.

Badawy AA-B Dougherty DM Richard DM (2010) Specificity of the acute tryptophan and tyrosine plus phenylalanine depletion and loading tests Part II: Normalisation of the tryptophan and tyrosine plus phenylalanine to competing amino acid ratios in a new control formulation. Int J Tryptophan Res 3: 35–47.

Banki CM Molnar G (1981) Cerebrospinal fluid 5-hydroxindoleacetic acid as an index of central serotonergic processes. Psychiatry Res 5: 23–32.

Barton DA Esler MD Dawood T (2008) Elevated brain serotonin turnover in patients with depression: Effect of genotype and therapy. Arch Gen Psychiat 65: 38–46.

Baughman KL Franz JM (1971) Control of tryptophan oxygenase and formamidase activity in the gerbil. Int J Biochem 2: 201–211.

Bender DA (1982) Biochemistry of tryptophan in health and disease. Molec Aspects Med 6: 101–197.

Bonkale WL Murdock S Janosky JE (2004) Normal levels of tryptophan hydroxylase immunoreactivity in the dorsal raphé of depressed suicide victims. J Neurochem 88: 958–964.

Cook JS Pogson CI Smith SA (1980) Indoleamine 2,3-dioxygenase. A new, rapid, sensitive radiometric assay and its application to the study of the enzyme in rat tissues. Biochem J 189: 461–466.

Costa C De Antoni A Bacchichetti F (1984) Metabolites and enzyme activities involved in tryptophan metabolism in two different strains of mouse. Ital J Biochem 33: 319–324.

Gjerris A (1988) Do concentrations of neurotransmitters in lumbar CSF reflect cerebral dysfunction in depression? Acta Psychiat Scand Suppl 345: 21–24.

Green AR Sourkes TL Young SN (1975) Liver and brain tryptophan metabolism following hydrocortisone administration to rats and gerbils. Br J Pharmacol 53: 287–292.

Hou C Jia F Liu Y (2006) CSF serotonin, 5-hydroxyindoleacetic acid and neuropeptide Y levels in severe major depressive disorder. Brain Res 1095: 154–158.

Huether G Hajak G Reimer A (1992) The metabolic fate of infused L-tryptophan in men: Possible clinical implications of the accumulation of circulating tryptophan and tryptophan metabolites. Psychopharmacol 109: 422–432.

Kennedy JS Gwirtsman HE Schmidt DE (2002) Serial cerebrospinal fluid tryptophan and 5-hydroxy indoleacetic acid concentrations in healthy human subjects. Life Sci 23: 1703–1715.

Knox WE (1966) The regulation of tryptophan pyrrolase activity by tryptophan. Adv Enzyme Regul 4: 287–297.

Larsson M Forsman A Hallgren J (1988) HPLC assays of 5-HIAA and tryptophan in cerebrospinal fluid and 5-HT and tryptophan in blood: A methodological study with clinical applications. Methods Find Exp Clin Pharmacol 10: 453–460.

Meltzer HY Lowy MT (1987) The serotonin hypothesis of depression. In: Meltzer HY (ed) Psychopharmacology: The Third Generation of Progress, New York: Raven Press, pp.513–526.

Meyer JH Ginovart N Boovariwala A (2006) Elevated monoamine oxidase a levels in the brain: An explanation of the monoamine imbalance of major depression. Arch Gen Psychiat 63: 1209–1216

Monroe CB (1968) Induction of tryptophan pyrrolase and tyrosine aminotransferase in mice. Am J Physiol 214: 1410–1414.

Moreno FA Parkinson D Palmer C (2010) CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls. Eur Neuropsychopharmacol 20: 18–24.

Nordin C (1988) Relationship between clinical symptoms and monoamine metabolite concentrations in biochemically defined subgroups of depressed patients. Acta Psychiat Scand 78: 720–729.

Opmeer EM Kortekaas S Aleman A (2010) Depression and the role of genes involved in dopamine metabolism and signalling. Progr Neurobiol 92: 112–133.

Sedlmayr P Blaschitz A Wintersteiger R (2002) Localisation of indoleamine 2,3-dioxygenase in human female reproductive organs and placenta. Mol Human Reprod 8: 385–391.

Yamazaki F Kuroiwa T Takikawa O (1985) Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme. Biochem J 230: 635–638.

Young SN (2013) Tryptophan and inhibitors of tryptophan 2,3-dioxygenase as antidepressants. J Psychopharmacol (in press).

Young SN Gauthier S (1981) Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid, and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiat 44: 323–327.

Young SN Lal S Martin JB (1973) 5-Hydroxyindoleacetic acid, homovanillic acid and tryptophan levels in CSF above and below a complete block of CSF flow. Psychiat Neurol Neurochir 76: 439–444.

Yuwiler A Brammer GL Morley JE (1981) Short-term and repetitive administration of oral tryptophan in normal men. effects on blood tryptophan, serotonin, and kynurenine concentrations. Arch Gen Psychiat 38: 619–626.